PortfoliosLab logoPortfoliosLab logo
CDNA vs. AIOS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CDNA vs. AIOS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CareDx, Inc (CDNA) and AIOS Tech, Inc. (AIOS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CDNA achieves a 32.96% return, which is significantly higher than AIOS's -45.51% return.


CDNA

1D
-4.32%
1M
15.81%
YTD
32.96%
6M
25.12%
1Y
31.57%
3Y*
47.04%
5Y*
-23.19%
10Y*
18.09%

AIOS

1D
-13.31%
1M
-27.40%
YTD
-45.51%
6M
-59.23%
1Y
-82.67%
3Y*
-46.37%
5Y*
-64.97%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CDNA vs. AIOS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CDNA
CareDx, Inc
32.96%-12.00%78.42%5.17%-74.91%-37.23%235.88%-14.20%242.51%171.85%
AIOS
AIOS Tech, Inc.
-45.51%-84.05%67.75%-29.78%-82.26%-82.37%213.97%584.53%-67.78%-46.87%

Correlation

The correlation between CDNA and AIOS is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Dec 27, 2016

0.13

Fundamentals

Market Cap

CDNA:

$1.33B

AIOS:

$2.70M

EPS

CDNA:

-$0.15

AIOS:

-$955.63

PS Ratio

CDNA:

3.22

AIOS:

0.01

PB Ratio

CDNA:

4.24

AIOS:

0.58

Total Revenue (TTM)

CDNA:

$412.82M

AIOS:

$344.69M

Gross Profit (TTM)

CDNA:

$198.97M

AIOS:

$33.75M

EBITDA (TTM)

CDNA:

$4.15M

AIOS:

$9.69M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CDNA vs. AIOS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CDNA
CDNA Risk / Return Rank: 5959
Overall Rank
CDNA Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
CDNA Sortino Ratio Rank: 5757
Sortino Ratio Rank
CDNA Omega Ratio Rank: 6363
Omega Ratio Rank
CDNA Calmar Ratio Rank: 5858
Calmar Ratio Rank
CDNA Martin Ratio Rank: 5858
Martin Ratio Rank

AIOS
AIOS Risk / Return Rank: 1717
Overall Rank
AIOS Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
AIOS Sortino Ratio Rank: 2424
Sortino Ratio Rank
AIOS Omega Ratio Rank: 2323
Omega Ratio Rank
AIOS Calmar Ratio Rank: 66
Calmar Ratio Rank
AIOS Martin Ratio Rank: 99
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CDNA vs. AIOS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CareDx, Inc (CDNA) and AIOS Tech, Inc. (AIOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CDNAAIOSDifference
Sharpe ratioReturn per unit of total volatility

+0.88

Sortino ratioReturn per unit of downside risk

+1.40

Omega ratioGain probability vs. loss probability

1.17

0.95

+0.22

Calmar ratioReturn relative to maximum drawdown

0.72

-0.91

+1.63

Martin ratioReturn relative to average drawdown

1.50

-1.39

+2.89

CDNA vs. AIOS - Sharpe Ratio Comparison

The current CDNA Sharpe Ratio is 0.44, which is higher than the AIOS Sharpe Ratio of -0.44. The chart below compares the historical Sharpe Ratios of CDNA and AIOS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CDNA vs. AIOS - Drawdown Comparison

The maximum CDNA drawdown since its inception was -94.87%, roughly equal to the maximum AIOS drawdown of -99.84%. Use the drawdown chart below to compare losses from any high point for CDNA and AIOS.


Loading charts...

Drawdown Indicators


CDNAAIOSDifference

Max Drawdown

Largest peak-to-trough decline

-94.87%

-99.84%

+4.97%

Max Drawdown (1Y)

Largest decline over 1 year

-43.92%

-91.43%

+47.51%

Max Drawdown (3Y)

Largest decline over 3 years

-65.96%

-98.13%

+32.17%

Max Drawdown (5Y)

Largest decline over 5 years

-94.85%

-99.76%

+4.91%

Max Drawdown (10Y)

Largest decline over 10 years

-94.87%

Current Drawdown

Current decline from peak

-73.80%

-99.76%

+25.96%

Average Drawdown

Average peak-to-trough decline

-53.75%

-74.24%

+20.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.10%

59.53%

-38.43%

Volatility

CDNA vs. AIOS - Volatility Comparison

The current volatility for CareDx, Inc (CDNA) is 16.23%, while AIOS Tech, Inc. (AIOS) has a volatility of 40.60%. This indicates that CDNA experiences smaller price fluctuations and is considered to be less risky than AIOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CDNAAIOSDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.23%

40.60%

-24.37%

Volatility (6M)

Calculated over the trailing 6-month period

45.88%

161.43%

-115.55%

Volatility (1Y)

Calculated over the trailing 1-year period

72.34%

186.76%

-114.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.50%

126.95%

-49.45%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.19%

113.05%

-34.86%

Dividends

CDNA vs. AIOS - Dividend Comparison

Neither CDNA nor AIOS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CDNA vs. AIOS - Financials Comparison

This section allows you to compare key financial metrics between CareDx, Inc and AIOS Tech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-100.00M0.00100.00M200.00M300.00M20222023202420252026
117.70M
-85.83M
(CDNA) Total Revenue
(AIOS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CDNA and AIOS have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AIOS has higher volatility (40.60%) compared to CDNA (16.23%). In terms of maximum drawdown, CDNA dropped -94.87% vs AIOS's -99.84%.

CDNA currently has the higher Sharpe Ratio (0.44 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CDNA and AIOS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer